Skip to main content
. 2017 Jan 20;18(1):210. doi: 10.3390/ijms18010210
ALL acute lymphoblastic leukemia
ATM ataxia telangiectasia mutated
ATR ataxia telangiectasia and rad3-related protein
BER base-excision repair
BRCA breast-related cancer antigens
CA-125 cancer antigen 125
DDR DNA damage response
DSBs double-strand breaks
eIF4E eukaryotic translation initiation factor 4E
EOC epithelial ovarian cancer
ER estrogen receptor
HER2 human epidermal growth factor receptor 2
HGSOC high-grade serous ovarian cancer
HR homologous recombination DNA repair
HRD homologous recombination DNA repair deficiency
IGF-R insulin-like growth factor receptor
LGSOC low-grade serous ovarian cancer
MAPK mitogen-activated protein kinase
MEK MAPK/ERK kinase
mTOR mammalian target of rapamycin
mTORC1 mammalian target of rapamycin complex 1
MDM2 murine double minute 2
MYC v-myc avian myelocytomatosis viral oncogene homolog
OC ovarian cancer
PARP poly ADP-ribose polymerase
PDX patient-derived xenograft
PI3K phosphatidylinositol-3-kinase
Pol I RNA polymerase I
Pol II RNA polymerase II
Pol III RNA polymerase III
PTEN phosphatase and tensin homolog
RAS retrovirus-associated DNA sequences
rDNA ribosomal DNA
rRNA ribosomal RNA
RPs ribosomal proteins
SL-1 selectivity factor 1
TERT telomerase reverse transcriptase
UBF upstream binding factor
VEGF vascular endothelial growth factor